Key points are not available for this paper at this time.
This study highlights IL-6 as a potential biomarker and key player in CAD pathogenesis. These findings warrant further investigation into the therapeutic potential of targeting inflammatory pathways for cardiovascular risk reduction.
Altyar et al. (Fri,) studied this question.